19
Jul
2010
Stemgent, Inc.: Series B $5.6M
Posted in I - Series B, Q - 2Q10, R - NORTH EAST, X - Reagent, X - Stem Cell, XX - MA
Stemgent (Cambridge, MA) a commercial-stage supplier of stemcell related reagents and tools, closed a $5.6M Series B financing. Participants include HealthCare Ventures and Morgenthaler Ventures.
OnBioVC PARTNERS
-
